Social Democracy Then and Now

2002 ◽  
Vol 1 (1) ◽  
pp. 77-80 ◽  
Author(s):  
Robert Page
Keyword(s):  
Nineteenth Century ◽  
Social Democracy ◽  
Theory And Practice ◽  
Past Century ◽  
The West ◽  
Term Survival ◽  
Social Democratic ◽  
The Past ◽  
Constant Feature

C.A.R. Crosland (1956) The Future of Socialism, Jonathan Cape, London.Donald Sassoon (1997), One Hundred Years of Socialism, HarperCollins London. (First published by I.B.Tauris in 1996).John Callaghan (2000), The Retreat of Social Democracy, Manchester University Press, Manchester.Between them these three books provide an excellent overview of the theory and practice of social democracy as it has twisted and turned over the past century. As Sassoon reminds us in his magisterial review of the West European left, revisionism of one kind or another has been a constant feature of socialist discourse. The key question has always been whether such revisions have helped to bring about the transformation of capitalism (or, perhaps more realistically, its humanisation) or, in contrast, helped to secure its long-term survival. The first, and arguably the most controversial, revisionism of social democratic thought occurred in Germany at the end of the nineteenth century.

Cameralism as Sonderweg of German Mercantilism?

2021 ◽  
pp. 389-405
Author(s):  
Lars Magnusson
Keyword(s):  
Nineteenth Century ◽  
Political Economy ◽  
Theory And Practice ◽  
The Past ◽  
History Of

In recent years there has been a renewed interest in Cameralism, both as a discourse and as an administrative political economy, in both theory and practice. Attention has been drawn to how Cameralism—defined as thought and practice—should be understood. The aim of this article is to take a step back and focus on the historiography of Cameralism from the nineteenth century onwards. Even though many in recent times have challenged old and seemingly dated conceptualizations and interpretations, they are still very much alive. Most profoundly this has implied that Cameralism most often in the past has been acknowledged as an expression of—German. as it were—exceptionalism to the general history of economic doctrine and thinking.

scholarly journals Looking Back for the Future: Utilizing Sawfish Saws from Natural History Collections to Conserve the Critically Endangered Largetooth Sawfish (Pristis pristis)

2018 ◽  
Vol 2 ◽  
pp. e25806
Author(s):  
Annmarie Fearing ◽  
Kelcee Smith ◽  
Tonya Wiley ◽  
Jeff Whitty ◽  
Kevin Feldheim ◽  
...  
Keyword(s):  
Genetic Diversity ◽  
Natural History ◽  
Mitochondrial Control Region ◽  
Genetic Bottleneck ◽  
Critically Endangered ◽  
Past Century ◽  
Term Survival ◽  
Tissue Samples ◽  
The Past ◽  
Natural History Collections

The Critically Endangered (International Union for Conservation of Nature) largetooth sawfish, Pristispristis, was historically distributed in the tropical Pacific, Atlantic and Indian Oceans. Today, ‘viable’ populations are largely limited to northern Australia. Populations that have suffered from drastic declines in abundance, such as those experienced by P.pristis, are typically at risk of having reduced, or low, levels of genetic diversity. Previous research found that P.pristis in Australia have experienced a genetic bottleneck, but it is unclear whether this bottleneck is the result of contemporary declines over the last century, or if it is the result of historic processes. A direct way to assess whether this genetic bottleneck occurred relatively recently is to compare levels of genetic diversity in contemporary and historic populations. Sawfish saws that were taken as trophies over the past century can now be found in natural history collections around the world and can provide DNA from past sawfish populations. We collected tissue samples from 150 dried P.pristis saws found in both private and public natural history collections. Because DNA from natural history specimens tends to be highly degraded, we targeted ten small DNA fragments, ~150 base pairs each, to amplify and sequence the entire mitochondrial control region. These data will provide important baseline information about P.pristis that can be used to quantify any loss of genetic diversity over the past ~100 years and assess their long-term survival potential. If the levels of genetic diversity in contemporary populations are severely reduced from those of past populations, protecting remaining genetic diversity within and between viable populations should be a priority in conservation plans.

Social Democrats I

Just Property ◽  
2020 ◽  
pp. 108-137
Author(s):  
Christopher Pierson
Keyword(s):  
Nineteenth Century ◽  
Interwar Period ◽  
Functional Property ◽  
Social Democracy ◽  
Social Democrats ◽  
Social Democratic ◽  
The Press ◽  
British Case ◽  
Further Development

This chapter begins with a brief discussion of what we mean by social democracy. I explore the origins of a distinctively social democratic view in mid-nineteenth century Europe, above all through the work of Louis Blanc and Ferdinand Lassalle. I plot its further development, above all in the context of German social democracy and the work of Bernstein, Kautsky, Luxemburg, and Jaurès. I turn to the British case to consider the further development of these ideas in the interwar period, above all in changing views of nationalization, planning, taxation, and ‘functional property’. Key thinkers in this process include Tawney, Jay, and Keynes. The earliest social democrats had very clear views about the need to socialize the ownership of property. Later social democrats, under the press of a politics that was electorally feasible, sought to fudge the hard questions on property.

scholarly journals Evolving impact of long-term survival results on metastatic melanoma treatment

2020 ◽  
Vol 8 (2) ◽  
pp. e000948 ◽  
Author(s):  
Olivier Michielin ◽  
Michael B Atkins ◽  
Henry B Koon ◽  
Reinhard Dummer ◽  
Paolo Antonio Ascierto
Keyword(s):  
Targeted Therapies ◽  
Survival Data ◽  
Long Term Results ◽  
Tumor Type ◽  
Term Survival ◽  
Long Term Survival ◽  
The Past ◽  
Number Of Patients ◽  
Melanoma Treatment

Melanoma treatment has been revolutionized over the past decade. Long-term results with immuno-oncology (I-O) agents and targeted therapies are providing evidence of durable survival for a substantial number of patients. These results have prompted consideration of how best to define long-term benefit and cure. Now more than ever, oncologists should be aware of the long-term outcomes demonstrated with these newer agents and their relevance to treatment decision-making. As the first tumor type for which I-O agents were approved, melanoma has served as a model for other diseases. Accordingly, discussions regarding the value and impact of long-term survival data in patients with melanoma may be relevant in the future to other tumor types. Current findings indicate that, depending on the treatment, over 50% of patients with melanoma may gain durable survival benefit. The best survival outcomes are generally observed in patients with favorable prognostic factors, particularly normal baseline lactate dehydrogenase and/or a low volume of disease. Survival curves from melanoma clinical studies show a plateau at 3 to 4 years, suggesting that patients who are alive at the 3-year landmark (especially in cases in which treatment had been stopped) will likely experience prolonged cancer remission. Quality-of-life and mixture-cure modeling data, as well as metrics such as treatment-free survival, are helping to define the value of this long-term survival. In this review, we describe the current treatment landscape for melanoma and discuss the long-term survival data with immunotherapies and targeted therapies, discussing how to best evaluate the value of long-term survival. We propose that some patients might be considered functionally cured if they have responded to treatment and remained treatment-free for at least 2 years without disease progression. Finally, we consider that, while there have been major advances in the treatment of melanoma in the past decade, there remains a need to improve outcomes for the patients with melanoma who do not experience durable survival.

Rolling and Trembling of the Abdomen: Movement as a Subaltern Subject in Colonial Egypt

2016 ◽  
Vol 2016 ◽  
pp. 141-147
Author(s):  
Maria Faidi
Keyword(s):  
Nineteenth Century ◽  
Power Relations ◽  
Historical Context ◽  
Past Century ◽  
Belly Dance ◽  
British Colonialism ◽  
Feminist Analysis ◽  
The Past ◽  
Egyptian Culture ◽  
Subaltern Subject

Accordingly to Shay and Sellers-Young (2005) “the term “belly dance” was adopted by natives and non-natives to denote all solo dance forms from Morocco to Uzbekistan that engage the hips, torso, arms and hands in undulations, shimmies, circles and spirals.” Dance historian Curt Sachs depicted the dance as “the swinging of the rectus abdominis” (Sachs 1963). This movement has been performed by many oriental dancers in the past century and has become part of the routine of oriental dancers worldwide. This movement has even named the dance “belly dance,” and become one of the most representative elements of contemporary Egyptian culture.This paper will be organized as follows: firstly, I am going to explain succinctly how I use the term “subaltern” in relation to dance and colonialism. Secondly, I am going to present the main scenarios, actors, and factors in which the rolling and trembling of the abdomen was danced, watched, desired and hated at the end of the nineteenth century, provoking strong love/hate reactions among the fin de siecle public. The discourse intermingles both dance and feminist analysis observing how movement constituted a metaphor of the unequal power relations between the metropolis and the colony within the particular historical context of British colonialism in Egypt.

scholarly journals How I treat relapsed acute lymphoblastic leukemia in the pediatric population

Blood ◽  
2020 ◽  
Vol 136 (16) ◽  
pp. 1803-1812 ◽  
Author(s):  
Stephen P. Hunger ◽  
Elizabeth A. Raetz
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Pediatric Population ◽  
Lymphoblastic Leukemia ◽  
Treatment Options ◽  
Survival Rates ◽  
Treatment Decision ◽  
Term Survival ◽  
Hematopoietic Stem ◽  
The Past

Abstract Relapsed acute lymphoblastic leukemia (ALL) has remained challenging to treat in children, with survival rates lagging well behind those observed at initial diagnosis. Although there have been some improvements in outcomes over the past few decades, only ∼50% of children with first relapse of ALL survive long term, and outcomes are much worse with second or later relapses. Recurrences that occur within 3 years of diagnosis and any T-ALL relapses are particularly difficult to salvage. Until recently, treatment options were limited to intensive cytotoxic chemotherapy with or without site-directed radiotherapy and allogeneic hematopoietic stem cell transplantation (HSCT). In the past decade, several promising immunotherapeutics have been developed, changing the treatment landscape for children with relapsed ALL. Current research in this field is focusing on how to best incorporate immunotherapeutics into salvage regimens and investigate long-term survival and side effects, and when these might replace HSCT. As more knowledge is gained about the biology of relapse through comprehensive genomic profiling, incorporation of molecularly targeted therapies is another area of active investigation. These advances in treatment offer real promise for less toxic and more effective therapy for children with relapsed ALL, and we present several cases highlighting contemporary treatment decision-making.

Intensive Asparaginase Therapy in Young Adult Patients with Acute Lymphoblastic Leukemia: Treatment Patterns and Barriers to Asparaginase Use

Blood ◽  
2015 ◽  
Vol 126 (23) ◽  
pp. 4913-4913
Author(s):  
Leonard S Sender ◽  
Tina Doede ◽  
Megan P. Hall ◽  
Celine Bernard
Keyword(s):  
Overall Survival ◽  
Acute Lymphoblastic Leukemia ◽  
Young Adult ◽  
Lymphoblastic Leukemia ◽  
Adult Patients ◽  
Employment Equity ◽  
Term Survival ◽  
The Past ◽  
Equity Ownership

Abstract Background : Although considerable progress has been made in treating acute lymphoblastic leukemia (ALL) in the pediatric population, with long-term survival exceeding 80%, the prognosis for adolescents, young adult, and adult patients with ALL remains poor, with only 30%-45% of patients achieving long-term survival. Several studies suggest that young adult patients have superior overall survival when treated with intensive "pediatric-inspired" regimens that include the use of asparaginase [Dombret H, et al. Curr Hematol Malig Rep. 2014;9(2):158-164]. Despite these results, many young adult patients with ALL continue to be treated with chemotherapy regimens that include little or no asparaginase. The goal of this study was to assess the views and practices of hematologists and oncologists with respect to asparaginase use in young adult patients with ALL. Methods : This study was conducted between May 14 and June 22, 2015, and consisted of a 10-minute online quantitative survey, with a 10-minute per-patient chart audit component for up to 4 charts provided by participating physicians. The survey targeted physicians treating young adult patients (aged 18-40 years) with ALL. To be included in the final analysis, physicians were required to be board certified with 2-30 years in practice, with ≥75% of their time spent in direct patient care and ≥20% of their time spent in an academic setting (NCCN/NCI or academic/teaching hospital). Inclusion criteria also required that physicians' total ALL patient volume (young adults and adults aged >40 years) was greater than 5 over the past 2 years, that the physician primarily treats adult patients, and has personally managed and treated at least 1 young adult ALL patient in the past 2 years. Results: The study included results reported by a total of 63 practicing physicians for 189 young adult patients with ALL (62% were aged 25-40 years). Sixty percent (114/189) of young adult patients were treated with a protocol that included asparaginase, and only 29% (55/189) on a pediatric-inspired protocol. The most common protocols reported for patients receiving asparaginase included the pediatric-inspired CALGB 10403 (18%, 21/114), as well as regimens with more limited asparaginase use, including augmented hyper-CVAD (29%, 33/114) and CALGB 8811 (12%, 14/114). Overall 40% (75/189) of young adult patients were treated with protocols that did not include asparaginase, most commonly hyper-CVAD (77%, 58/75). Fifty percent (18/36) of responding physicians using hyper-CVAD reported the perception of similar outcomes with nonasparaginase regimens as with asparaginase-intensive regimens. When questioned about the greatest barrier to the use of intensive asparaginase-containing regimens, 88% (7/8) of responding physicians reported safety and tolerability concerns. Conclusion: Only 6 out of 10 patients in the study were treated with an asparaginase-containing regimen; of all patients, less than 1 out of 3 received a pediatric-inspired regimen. Fifty-three percent (60/114) of asparaginase-receiving patients were treated on a regimen that structures asparaginase dosing intermittently between alternating courses. Pediatric-inspired regimens include intensive asparaginase therapy and have consistently shown improvements in overall survival when compared with traditional adult protocols in clinical trials [Dombret H, et al. Curr Hematol Malig Rep. 2014;9(2):158-164]. Support: This study was funded by Jazz Pharmaceuticals. Disclosures Sender: Jazz Pharmaceuticals: Research Funding, Speakers Bureau. Doede:Jazz Pharmaceuticals: Employment, Equity Ownership. Hall:Jazz Pharmaceuticals: Employment, Equity Ownership. Bernard:Jazz Pharmaceuticals: Employment, Equity Ownership.

Adjuvant Chemotherapy in Patients with Osteosarcoma

2011 ◽  
Vol 07 (03) ◽  
pp. 183
Author(s):  
Noah Federman ◽  
William Tap ◽  
◽  
Keyword(s):  
Young Adults ◽  
Adjuvant Chemotherapy ◽  
Malignant Neoplasm ◽  
Chemotherapeutic Agents ◽  
Term Survival ◽  
Future Directions ◽  
The Past ◽  
Metastatic Osteosarcoma ◽  
Improvement In Survival

Osteosarcoma is the most common primary malignant neoplasm of bone in children, adolescents and young adults. Prior to 1970, the outcome for patients with osteosarcoma was dismal, with only 10–20 % of patients achieving long-term survival. The improvement in survival over the past four decades, now approaching 75 %, has largely been due to the addition of adjuvant chemotherapy to surgery. However, for patients that have metastatic osteosarcoma or recurrence of their cancer, the outlook is poor and the prognosis has not improved over the past several decades, despite the advent and use of newer chemotherapeutic agents and combinations. This review will focus on the current chemotherapeutic treatments of localised osteosarcoma, the controversies surrounding adjuvant therapy and future directions and additions to our armamentarium.

Future Impossible Communities

2020 ◽  
Vol 24 (1) ◽  
pp. 96-102
Author(s):  
Jossianna Arroyo
Keyword(s):  
Nineteenth Century ◽  
Twentieth Century ◽  
Puerto Rico ◽  
West Indies ◽  
Special Section ◽  
The West ◽  
Spanish Caribbean ◽  
The Past ◽  
Critical Intervention ◽  
Key Interventions

This response essay reviews the six contributions to the special section “Con-Federating the Archipelago: The Confederación Antillana and the West Indies Federation.” These key interventions on the Spanish Caribbean Confederation projects in the nineteenth century and the West Indies Federation in the twentieth century provoke the following questions: Could we call these two Caribbean confederation projects failures if their centrality in Caribbean political imaginaries suggests otherwise? What are some of the insights that these two projects could offer to Caribbean sociohistorical processes, culture, and political developments? Even though these two projects seem to share a similar political goal, they are also radically different. The author reviews the contributions to the special section in dialogue with examples from Puerto Rico in order to assess the critical intervention in theories of nationalism produced by the past projects of federation and the possible futures they give rise to.

British psychiatry and homosexuality

1999 ◽  
Vol 175 (2) ◽  
pp. 106-113 ◽  
Author(s):  
Michael King ◽  
Annie Bartlett
Keyword(s):  
Mental Health ◽  
Gay Men ◽  
19Th Century ◽  
Mental Health Professionals ◽  
Health Professionals ◽  
Theory And Practice ◽  
Past Century ◽  
The Past ◽  
The 19Th Century ◽  
Behavioural Sciences

BackgroundOpposition to homosexuality in Europe reached a crescendo in the 19th century. What had earlier been regarded as a vice evolved as a perversion or psychological illness. Official reviews of homosexuality as both an illness and (for men) a crime led to discrimination, inhumane treatments and shame, guilt and fear for gay men and lesbians. Only recently has homosexuality been removed from all international diagnostic glossaries.AimsTo review how British psychiatry has regarded homosexuality over the past century.MethodReview of key publications on homosexuality in British psychiatry.ResultsThe literature on homosexuality reflects evolving theories on sexuality over the past century. The assumptions in psychoanalysis and the behavioural sciences that sexuality could be altered led to unscientific theory and practice.ConclusionsMental health professionals in Britain should be aware of the mistakes of the past. Only in that way can we prevent future excesses and heal the gulf between gay and lesbian patients and their psychiatrists.

Sign in / Sign up

Export Citation Format

Share Document